283 related articles for article (PubMed ID: 36553594)
21. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
22. Prediction of Necroptosis-Related Markers in Head and Neck Carcinoma by Bioinformatics.
Zheng L; Li M; Gu R; Zhang H; Qi X; Dong H
J Immunol Res; 2022; 2022():1993023. PubMed ID: 35785035
[TBL] [Abstract][Full Text] [Related]
23. Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients.
Sabarimurugan S; Madurantakam Royam M; Das A; Das S; K M G; Jayaraj R
Mol Diagn Ther; 2018 Dec; 22(6):653-669. PubMed ID: 30259393
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Jamali Z; Asl Aminabadi N; Attaran R; Pournagiazar F; Ghertasi Oskouei S; Ahmadpour F
Oral Oncol; 2015 Apr; 51(4):321-31. PubMed ID: 25677760
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA expression in osteoarthritis: a meta-analysis.
Liu H; Yan L; Li X; Li D; Wang G; Shen NN; Li JJ; Wang B
Clin Exp Med; 2023 Nov; 23(7):3737-3749. PubMed ID: 37027064
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
27. Identification of candidate microRNA biomarkers in renal fibrosis: a meta-analysis of profiling studies.
Gholaminejad A; Abdul Tehrani H; Gholami Fesharaki M
Biomarkers; 2018 Dec; 23(8):713-724. PubMed ID: 29909697
[TBL] [Abstract][Full Text] [Related]
28. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
29. Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: a meta-analysis.
Zhang M; Zhao LJ; Liang WQ; Mao ZP
Genet Mol Res; 2015 Dec; 14(4):16562-76. PubMed ID: 26681002
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Sabarimurugan S; Madhav MR; Kumarasamy C; Gupta A; Baxi S; Krishnan S; Jayaraj R
Mol Diagn Ther; 2020 Feb; 24(1):15-30. PubMed ID: 32020560
[TBL] [Abstract][Full Text] [Related]
31. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
32. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
33. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
34. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
35. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
[TBL] [Abstract][Full Text] [Related]
36. Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium.
Pastorino R; Sassano M; Danilo Tiziano F; Giraldi L; Amore R; Arzani D; Abiusi E; Ahrens W; Vilches LA; Canova C; Healy CM; Holcatova I; Lagiou P; Polesel J; Popovic M; Nygård S; Cadoni G; Znaor A; Boffetta P; Matsuo K; Oze I; Brennan P; Boccia S
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2237-2243. PubMed ID: 36126276
[TBL] [Abstract][Full Text] [Related]
37. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis.
Li J; Wang P; Xu Y
PLoS One; 2017; 12(6):e0179536. PubMed ID: 28604812
[TBL] [Abstract][Full Text] [Related]
40. Prognostic miRNA classifiers in t cell acute lymphoblastic leukemia: Study protocol for a systematic review and meta-analysis of observational clinical studies.
Sabarimurugan S; Madurantakam Royam M; Kumarasamy C; Kodiveri Muthukaliannan G; Samiappan S; Jayaraj R
Medicine (Baltimore); 2019 Mar; 98(9):e14569. PubMed ID: 30817574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]